Celon Pharma S.A. (FRA:8RP)

Market Cap	249.50M -10.2%
Revenue (ttm)	52.87M +7.3%
Net Income	-28.68M
EPS	-0.55
Shares Out	n/a
PE Ratio	n/a
Forward PE	324.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	4.420
Previous Close	4.335
Day's Range	4.420 - 4.420
52-Week Range	4.265 - 5.770
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About Celon Pharma

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp. z o.o.

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 566
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8RP

Financial Performance

In 2024, Celon Pharma's revenue was 205.55 million, a decrease of -4.25% compared to the previous year's 214.66 million. Losses were -34.45 million, 22.5% more than in 2023.

Financial numbers in PLN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error